Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet

Archives of General Psychiatry

Volumn 53, Issue 6, 1996, Pages 531-536

  Coccaro, Emil F ^a   Kavoussi, Richard J ^a   Sheline, Yvette I ^b   Lish, Jennifer D ^a   Csernansky, John G ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN 1 RECEPTOR;

ADULT; AGGRESSION; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; DRUG BINDING; FEMALE; HUMAN; IMPULSIVENESS; MALE; PERSONALITY DISORDER; SEROTONINERGIC SYSTEM; THROMBOCYTE;

EID: 0029884262     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1996.01830060075010     Document Type: Article

References (48)

1. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979;1:131-139.
2. Brown GL, Ebert MH, Goyer PF, Jimerson OC, Klein WJ, Bunney WE, Goodwin FK. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry, 1982;139:741-746.
3. Limson R, Goldman D, Roy A, Lamparski D, Ravitz B, Adinoff B, Linnoila M. Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. Arch Gen Psychiatry. 1991;48:437-441.
4. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK. Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 1983;33:2609-2614.
5. Virkkunen M, Rawlins R, Tokola R, Poland RE, Guidotti A, Nemeroff C, Bisssette G, Kalogeras K, Karonen SL, Linnoila M. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholics, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry. 1994;51:20-27.
6. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL. Serotonergic studies in patients with affective and personality disorder: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry. 1989;46:587-599.
7. Moss HB, Yao JK, Panzak GL. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry. 1990;28:325-338.
8. Higley JD, Mehlman PT, Taub DM, Higley SB, Suomi SJ, Linnoila M, Vickers JH. Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys. Arch Gen Psychiatry. 1992;49:436-441.
9. Mehlman PT, Higley JD, Faucher I, Lilly AA, Taub DM, Vickers J, Suomi SJ, Linnoila M. Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in non-human primates. Am J Psychiatry. 1994;151: 1485-1491.
10. Botchin MB, Kaplan JR, Manuck SB, Mann JJ. Low versus high prolactin responders to fenfluramine challenge: marker of behavioral differences in adult male cynomolgus macaques. Neuropsychopharmacology. 1993;9:93-99.
11. Coccaro EF. Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavioral relationship, Int J Clin Psychopharmacol. 1992;7:3-12.
12. Coccaro EF, Astill J. Central serotonergic function in parasuicide. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:663-674.
13. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization Proc Natl Acad Sci USA. 1993;90:2542-2546.
14. Leseh K-P, Wolozin BL, Murphy DL, Riederer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochemistry. 1993;60:2319-2322.
15. Marcusson J, Ross SB. Binding of some antidepressants to the 5-hydroxytryptamine transporter in biain and platelets. Psychopharmacology. 1990;102: 145-155.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
17. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry. 1982;39:879-883.
18. Klein DN, Ouimette PC, L Kelly HS, Ferro T, Riso LP, Test-retest reliability of a team consensus best-estimate diagnoses ot Axis I and II disorders in a family study. Am J Psychiatry. 1994;151:1043-1047.
19. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia. NY State Psychiatric Institute; New York: 1978.
20. Pfohl B, Zimmerman M. Structured Interview for the Diagnosis of DSM-III-R Personality Disorders. Iowa City; University of Iowa College of Medicine: 1989.
21. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol. 1957;21:343-348.
22. Barratt ES. Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Reports. 1985;16:547-554.
23. Guy W. ECDEU Manual for Psychopharmacology. Washington, DC: Superintendent of Documents, US Government Printing Office; 1976. US Dept of Health, Education, and Welfare publication ADM 76-338.
24. Coccaro EF, Lawrence T, Trestman R, Gabriel S, Klar HM, Siever LJ, Growth hormone responses to intravenous clonidine challenge correlates with behavioral irritability in psychiatric patients and in healthy volunteers. Psychiatry Res. 1991;39:129-139.
25. Seiver LJ, Amin F, Coccaro EF, Bernstein DP, Kavoussi RJ, Kalus O, Horvath TB, Warne P, Davidson M, Davis KL. Plasma homovanillic acid in schizotypal personality disorder. Am J Psychiatry. 1991;148:1246-1248.
26. 3H-paroxetine binding with the 5-HT transporter in brain and platelet: relevance to studies in depression. J Receptor Res. 1987;7:499-525.
27. Marazziti D, DeLeo D, Conti L. Further evidence supporting the role of the serotonin system in suicidal behavior: a preliminary study of suicide attempters. Acts Psychiatr Scand. 1989;80:322-324.
28. 3H-imipramine binding sites: association with serotonergic neurons. Brain Res Bull. 1983;11:325-334.
29. 3H-paroxetine binding to rat cortical membranes. Eur J Pharmacol. 1985;118: 107-114.
30. 3H-imipramine to rat neuronal membranes. Psychopharmacology. 1986;89:436-439.
31. 3H-paroxetine. J Neurochemistry. 1989;52:1605-1612.
32. 3H-paroxetine-labeled serotonin uptake sites in rat brain. Synapse. 1987;1:488-496.
33. 3H-paroxetine binding in rat brain. J Neurochem. 1988;50:1783-1790.
34. 3H-paroxetine binding to platelets from healthy volunteers. Biol Psychiatry. 1993;34:356-360.
35. 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age. Psychiatry Res. 1994;51:147-155.
36. Kühn DM, Wolf W, Youdim MBH. Serotonin neurochemistry revisited: a new look at some old axioms. Neurochem Int. 1986;2:141-154.
37. Asberg M, Schalling D, Traksman-Bendz L, Wagner A. Psychobiology of suicide, impulsivity, and related phenomena. In: Meltzer HY, ed. Psychopharmacology: Third Generation of Progress. New York, NY: Raven Press; 1987:655-688.
38. Blier P, de Montigny C, Chaput Y. Modifications of the serotonin system by antidepressant treatments: implication for the therapeutic response in major depression. J Clin Psychopharmacol. 1987;7(suppl):24S-35S.
39. Aghajanian GK. Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. In: Youdim MBH, Lovenberg W, Shaman DF, Langnado JR, eds. Essays in Neurochemistry and Neuropharmacology. New York, NY; Wiley & Sons: 1978;3:1-33.
40. O'Keane V, Dinan TG. Prolactin and cortisol responses to D-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. Am J Psychiatry. 1991;148:1009-1015.
41. O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG. Blunted prolactin responses to D-fenfluramine in sociopathy: evidence for subsensitivity of central serotonergic function. Br J Psychiatry. 1992;160:643-646.
42. Marazziti D, Rotondo A, Presta S, Panioli-Guadagnucci ML, Palego L, Conti L. Role of serotonin in human aggressive behavior. Aggressive Behav. 1993;9: 347-353.
43. 3H-imipramine binding sites on platelets of conduct disordered children. Neuropsychopharmacology. 1987;1:55-62.
44. Birmaher B, Stanley M, Greenhill L, Twomey J, Gavrilescu A, Rabinovich H. Platelet imipramine binding in children and adolescents with impulsive behavior. J Am Acad Child Adolesc Psychiatry. 1990;29:914-918.
45. Brown CS, Kent TA, Bryant SG, Gevedon RM, Campbell JL, Felthous AR, Barratt ES, Rose RM. Blood platelet uptake of serotonin in episodic aggression. Psychiatry Res. 1989;27:5-12.
46. Murphy DL, Mellow AM, Sunderland T, Aulahk CS, Lawlor BL, Zohar J. Strategies for assessing serotonin in humans. In: Coccaro EF, Murphy OL, eds. Serotonin in Major Psychiatric Disorders. Washington, DC: American Psychiatric Press; 1990.
47. Stanley MS, Viggilio J, Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science. 1982;216:1337-1339.
48. Gross-Isseroff R, Israeli M, Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Arch Gen Psychiatry. 1989;46:237-241.